Все
Издания
Соцсети
Карта зообизнеса
Профиль
Russia’s retail veterinary market saw significant growth in 2025, driven by a surge in domestic production and a shift toward premium pharmaceutical products. According to the latest data from RNC Pharma, total consumer spending on pet medications reached ₽49.1 billion, marking a 17.7% increase compared to the previous year.
In volume terms, the market grew by 14%, with 280.4 million minimum dosage units (MDU) sold. Analysts point to a steady rise in domestic consumption despite double-digit price inflation across the sector.
Domestic Surge vs. Import Stagnation
The year was defined by a clear pivot toward local manufacturers. Sales of Russian-made veterinary drugs jumped 36.9% in value and 26.7% in volume.
In contrast, foreign brands struggled to maintain their foothold. While import sales remained virtually flat in monetary terms (down 0.1%), they saw a sharp 11.1% decline in volume, suggesting that international players are losing market share to increasingly competitive local alternatives.
Pricing and Inflationary Pressure
The average price for veterinary medicines rose by 13% year-over-year. Notably, inflation within the domestic segment outpaced the market average, hitting 17% in the second half of 2025.
The Rise of the Premium Segment
One of the most striking trends of 2025 was the «premiumization» of the market. Sales of high-end drugs (priced over ₽1,000) nearly quadrupled, now accounting for 17.5% of total market value.
- Local Leader: The insecto-acaricide Tiksfly emerged as a top performer, with sales exceeding ₽1.3 billion.
- Foreign Dominance: Despite the domestic rise, foreign brands like Simparica and Bravecto continue to lead the premium sector, which represents 38.7% of all sales in the high-end category.
Meanwhile, the once-dominant mid-range segment (₽100–500) continues to shrink. Its market share has fallen from 62% in 2022 to just 44.6% in 2025, although traditional brands like Bars and Inspector remain staples for antiparasitic treatments.
Market Outlook
The 2025 figures underscore a structural shift in the Russian veterinary industry. The market is gravitating toward more expensive, sophisticated treatments, with domestic producers rapidly closing the gap with international competitors in both quality and consumer trust.
Source: RNC Pharma
Want to learn more about the Russian pet care market? Need help with your first steps? Please fill out the application form.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.
